If any of us hope to stop Donald Trump from becoming the 47th president of the United States, it will have to be done from the ballot box, not the courts.
pharmaceutical research
Follow:
-
Martin Shkreli Is An Example Of Why We Need Publicly Funded Pharmaceutical Research
Facing national outrage, the 32-year-old CEO backed down from the 5000% price increase his company announced this week for the malaria and toxoplasmosis drug Daraprim, sparking an overdue debate about the outlandish cost of life-saving medicines.